日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Metabolic heterogeneity signature of primary treatment-naïve prostate cancer

原发性未接受治疗的前列腺癌的代谢异质性特征

Lin, Dong; Ettinger, Susan L; Qu, Sifeng; Xue, Hui; Nabavi, Noushin; Choi, Stephen Yiu Chuen; Bell, Robert H; Mo, Fan; Haegert, Anne M; Gout, Peter W; Fleshner, Neil; Gleave, Martin E; Pollak, Michael; Collins, Colin C; Wang, Yuzhuo

Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell Carcinoma

肾细胞癌中,细胞对VEGF靶向抗血管生成疗法的适应性通过过度产生替代性内皮细胞生长因子诱导耐药性。

Han, Kyung Seok; Raven, Peter A; Frees, Sebastian; Gust, Kilian; Fazli, Ladan; Ettinger, Susan; Hong, Sung Joon; Kollmannsberger, Cristian; Gleave, Martin E; So, Alan I

Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway

抑制内质网分子伴侣蛋白葡萄糖调节蛋白78可通过抑制PERK/eIF2α通路增强肾细胞癌的抗血管生成治疗效果。

Han, Kyung Seok; Li, Na; Raven, Pater A; Fazli, Ladan; Frees, Sebastian; Ettinger, Susan; Park, Ki Chung; Hong, Sung Joon; Gleave, Martin E; So, Alan I

Hiding in plain view: genetic profiling reveals decades old cross contamination of bladder cancer cell line KU7 with HeLa.

隐藏在眼皮底下:基因分析揭示膀胱癌细胞系 KU7 与 HeLa 细胞系数十年前的交叉污染

Jäger Wolfgang, Horiguchi Yutaka, Shah Jay, Hayashi Tetsutaro, Awrey Shannon, Gust Kilian M, Hadaschik Boris A, Matsui Yoshiyuki, Anderson Shawn, Bell Robert H, Ettinger Susan, So Alan I, Gleave Martin E, Lee I-Ling, Dinney Colin P, Tachibana Masaaki, McConkey David J, Black Peter C

Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells

簇蛋白促进 COMMD1 和 I-κB 的降解,从而增强前列腺癌细胞中 NF-κB 的活性。

Zoubeidi, Amina; Ettinger, Susan; Beraldi, Eliana; Hadaschik, Boris; Zardan, Anousheh; Klomp, Leo W J; Nelson, Colleen C; Rennie, Paul S; Gleave, Martin E